I am a
Home I AM A Search Login

Papers of the Week

Papers: 24 Jul 2021 - 30 Jul 2021

Pharmacology/Drug Development

2021 Jul 22

Expert Rev Neurother

Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders.


Argyriou AA, Mitsikostas D-D, Mantovani E, Vikelis M, Tamburin S
Expert Rev Neurother. 2021 Jul 22.
PMID: 34289791.


Botulinum neurotoxin type-A (BoNTA) is licensed for the treatment of chronic migraine (CM), but it has been tested off-label as a therapeutic choice in other primary headaches (PHs). The authors aimed to provide a systematic review and expert opinion on BoNTA use in PHs, beyond CM.